Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, has been announced as the “Best Mobile App for Patient Engagement” winner of the 2026 MedTech Breakthrough Awards ...
LONDON, May 07, 2026--(BUSINESS WIRE)--causaLens, a London-based AI scaleup, today announced the expansion of its strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical ...
MORRISVILLE, N.C., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that CEO Alistair Macdonald has ...
Syneos Health had been eyeing a sale since March 2020. Apparently, for several years, many of the smaller drugmakers upon which Syneos relied for a big slice of its CRO business had delayed or dropped ...
Syneos Health cemented a multi-year deal to use Microsoft’s platform for deploying artificial intelligence (AI) in its clinical trials and commercial programs. The agreement announced this week ...
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated HUB ...
The companies initially partnered to execute advanced causal AI models to optimize commercial programs, pivoting from time-intensive data science tools to faster, AI-driven decision-making to speed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results